Early-Stage Pharmaceutical Marketing Budgets (PH95)

Fund early-stage marketing to realize products' commercial potential

Some project and brand teams make a critical mistake early in their drugs' development — they fail to adequately prepare the market for their products. Early-stage commercialization and market preparation deficiencies often are the result of insufficient funding rather than poor planning.

Don't allow your product's commercial potential to falter. Use Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch to bolster your case for larger commercial budgets and to benchmark your marketing spends in pre-clinical development, Phase 1 and Phase 2.

With spending data for the commercialization of 14 brands, this report analyzes early-phase resource allocation for products of all sizes — including niche products with modest budgets, mid-level products balancing their expenditures, and larger brands with blockbuster hopes. Each brand's data are presented in product profile format. The profiles break down each brand's commercialization budgets into 10 spending categories — providing our clients with more detailed budgets than were included in previous Cutting Edge Information reports or can be found in our competitors' reports today. The commercialization spending categories featured in this report include the following:

• Thought leader development
• Thought leader programs
• Medical education
• Medical information
• Market research
• Competitive intelligence
• Pricing strategy and analysis
• Pharmacoeconomics
• Reimbursement
• Advertising and promotions